Trisomy 8 is a chromosomal condition in which a person has three copies of chromosome 8 instead of the usual two. It exists in two forms: a complete version, where every cell in the body carries the extra chromosome, and a mosaic version, where only some cells are affected while others have the normal two copies. The mosaic form is far more common in living individuals, and is sometimes called Warkany syndrome.
Complete vs. Mosaic Trisomy 8
The distinction between the two forms matters enormously for what a person experiences. In complete trisomy 8, every cell in the body contains three copies of chromosome 8. This form is rarely seen in live births because it typically causes pregnancy loss early in development. Most miscarriages involving trisomy 8 are the complete form.
Mosaic trisomy 8 is what most people are referring to when they talk about this condition in children or adults. In the mosaic form, a person has two populations of cells: some with the normal two copies of chromosome 8 and some with three. The ratio of normal to abnormal cells varies from person to person, and this ratio plays a large role in how mild or severe the symptoms are. Someone with a small percentage of trisomic cells may have very subtle features, while someone with a higher percentage may experience more significant effects.
How It Happens
Trisomy 8 most often results from a cell division error that occurs after fertilization, not during the formation of the egg or sperm. A study examining the origins of chromosome 8 nondisjunction found that 20 out of 22 cases arose from a mitotic (postzygotic) duplication, meaning the error happened as the early embryo’s cells were dividing. Only two cases, both from spontaneous abortions, were traced back to a meiotic error in the mother’s egg cell. This is different from conditions like Down syndrome, where the extra chromosome usually originates before fertilization. Because the error in trisomy 8 typically happens after the embryo has already started developing, it naturally produces a mosaic pattern: cells that divided before the error are normal, and those that came after carry the extra chromosome.
Physical Features and Symptoms
The range of symptoms in mosaic trisomy 8 is broad. Some individuals appear almost unaffected, while others have a recognizable pattern of physical features. Common characteristics include distinctive facial features, skeletal abnormalities, joint problems, and abnormalities of the kidneys and heart. One particularly well-known physical sign is deep furrows on the soles of the feet, which clinicians often look for as a hallmark of the condition.
Skeletal issues can include abnormal curvature of the spine, extra or missing ribs, and limited range of motion in certain joints. Cardiac malformations, when present, vary in severity. Kidney abnormalities are also reported in a significant number of cases. The severity of any of these features depends largely on the proportion and distribution of trisomic cells in the body.
Cognitive and Developmental Effects
Intellectual disability is a recognized feature of mosaic trisomy 8, but it spans a wide range. Some individuals have mild learning differences and attend mainstream schools with support, while others have moderate intellectual disability. Delays in speech and motor development are common in early childhood. Psychomotor development (the ability to coordinate movement with thinking) may be slower than typical, though many children make steady progress with therapy and intervention over time.
Inflammatory and Blood-Related Complications
One aspect of trisomy 8 that often surprises people is its connection to inflammatory symptoms and blood disorders. Some children with the condition develop recurrent fevers, mouth ulcers, and abdominal pain that resemble an autoimmune or inflammatory condition similar to Behçet’s disease. These symptoms can be managed with anti-inflammatory medications, and in some cases, immunosuppressive therapies are used to control persistent inflammation.
Trisomy 8 also has a well-documented relationship with blood cancers. When trisomy 8 appears as an acquired change in bone marrow cells (rather than being present from birth), it is one of the most common chromosomal abnormalities found in myelodysplastic syndromes and acute myeloid leukemia. A study of 115 published cases where trisomy 8 was the only chromosomal change found that nearly 90% involved a myeloid blood disorder. Median survival in that group was about 17 months, with patients diagnosed with the precancerous condition (myelodysplastic syndrome) surviving longer, at a median of 21 months, compared to 15 months for those with acute leukemia. This acquired form of trisomy 8 in bone marrow is a separate situation from being born with the condition, but it illustrates how an extra copy of chromosome 8 can disrupt blood cell development.
How It Is Diagnosed
Mosaic trisomy 8 is diagnosed through genetic testing that examines a person’s chromosomes. A standard karyotype, which creates a visual map of all 46 chromosomes from a blood or tissue sample, can reveal the extra chromosome 8 in affected cells. Because the condition is mosaic, testing sometimes needs to examine a larger number of cells to catch the abnormality. If only a small percentage of cells carry the extra chromosome, a routine karyotype examining a limited number of cells could miss it.
A more targeted test called FISH (fluorescence in situ hybridization) can be used to specifically look for extra copies of chromosome 8. Johns Hopkins, for example, uses a single-color probe that attaches to the center of chromosome 8 and lights up under a microscope, making it straightforward to count copies in individual cells from blood or bone marrow samples. This method is particularly useful when monitoring for trisomy 8 in the context of blood disorders. Prenatal diagnosis is also possible through amniocentesis or chorionic villus sampling, though the mosaic nature of the condition can make results harder to interpret.
Management and Treatment
There is no single treatment for mosaic trisomy 8 because the condition affects each person differently. Management is tailored to whatever symptoms are present. A child with a heart defect may need cardiac monitoring or surgery. Kidney abnormalities may require imaging and follow-up with a specialist. Skeletal problems might be addressed through orthopedic care or physical therapy. Speech therapy and early intervention programs are commonly part of the plan for children with developmental delays.
For individuals who develop inflammatory symptoms like recurrent fevers or mouth ulcers, corticosteroids are widely used and can effectively control symptoms while reducing markers of inflammation. When corticosteroids alone are not enough, immunosuppressive medications or biologic therapies may be added to reduce reliance on steroids. In rare cases where the blood system is significantly affected and conventional medications are not working, bone marrow or stem cell transplantation may be considered as a way to replace the abnormal cell line entirely.
Long-Term Outlook
The prognosis for people born with mosaic trisomy 8 varies widely and depends heavily on which organs are affected and the proportion of trisomic cells. Many individuals with a lower percentage of abnormal cells live well into adulthood with mild features and a good quality of life. Those with more significant cardiac, kidney, or skeletal involvement need ongoing medical care but can still lead fulfilling lives. The condition is not inherently life-limiting in the way that some other trisomies are. Unlike trisomy 18, where the median survival is only days and fewer than 10% of affected infants reach their first birthday, mosaic trisomy 8 generally carries a much more favorable outlook. The key factor is early identification so that any organ involvement can be monitored and managed from the start.